FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On July 7, 2005
Table of Contents
Docket # Title
1989V-0161 VARIANCE FOR GRAND COULEE DAM LASER SHOW
1992V-0087 Laser effects for 'Fantasmic' show
1999V-1630 Laser Light Show
2000V-1453 Laser Light Show (Golden Dreams Laser Special Effects)
2000V-1576 AN/PEQ-2A, Target Pointer-Illuminator/Aiming Light
2002P-0135 Orally-Administered Levothyroxine Sodium all NDAs & ANDAs
2002V-0041 Laser Light Show
2002V-0265 Laser Light Show
2002V-0420 Laser light show
2003V-0042 Laser Light Show Projector
2004Q-0083 Qualified health claim (QHC): Green Tea and Reduced Risk of Cancer
2005N-0147 Sprout Safety Public Meeting
2005P-0076 OxyContin and Paladone removal from market and label changes limiting indications to severe chronic pain
2005P-0273 Add Calcium to the Mandatory List
2005P-0275 Request for a change to a listed drug to allow submission of an Abbreviated New Drug Application for Lidocaine Hydrochloride Injection USP, 2%.
2005Q-0211 Health Claim Notification: Whole Grains and Coronary Heart Disease
1989V-0161 VARIANCE FOR GRAND COULEE DAM LASER SHOW
VRA 6 HFZ-200 to U S Bureau of Reclamation Vol #: 1
1992V-0087 Laser effects for 'Fantasmic' show
VRA 6 HFZ-200 to Walt Disney Productions Vol #: 1
1999V-1630 Laser Light Show
VRA 4 HFZ-200 to Visual FX (Formerly Laser Laser Services) Vol #: 1
2000V-1453 Laser Light Show (Golden Dreams Laser Special Effects)
VRA 2 HFZ-200 to Walk Disney Productions Vol #: 1
2000V-1576 AN/PEQ-2A, Target Pointer-Illuminator/Aiming Light
VRA 4 HFZ-200 to Insight Technology Inc Vol #: 1
2002P-0135 Orally-Administered Levothyroxine Sodium all NDAs & ANDAs
M 8 HFD-630 Regarding ANDA 76-752 Vol #: 1
2002V-0041 Laser Light Show
VRA 2 HFZ-200 to Laser Wizardry East Vol #: 1
2002V-0265 Laser Light Show
VRA 2 HFZ-200 to Canobie Lake Park Vol #: 1
2002V-0420 Laser light show
VRA 2 HFZ-200 to Lasergrace Incorporated Vol #: 1
2003V-0042 Laser Light Show Projector
VRA 2 HFZ-200 to Laserwurx, LLC Vol #: 1
2004Q-0083 Qualified health claim (QHC): Green Tea and Reduced Risk of Cancer
LET 12
Attachment
Fleminger Inc Vol #: 8
LET 13 Fleminger Inc Vol #: 8
LET 14 Fleminger Inc Vol #: 8
LET 15 Fleminger Inc Vol #: 8
PDN 1 HFS-1 to Fleminger Inc Vol #: 9
2005N-0147 Sprout Safety Public Meeting
TR 1 Transcript of the May 17, 2005 Meeting Vol #: 2
2005P-0076 OxyContin and Paladone removal from market and label changes limiting indications to severe chronic pain
C 2 Form Letter Vol #: 2
2005P-0273 Add Calcium to the Mandatory List
ACK 1 HFA-305 to Rutgers University Vol #: 1
ACK 2 Number Not Used Vol #: 1
CP 1 Rutgers University Vol #: 1
2005P-0275 Request for a change to a listed drug to allow submission of an Abbreviated New Drug Application for Lidocaine Hydrochloride Injection USP, 2%.
CP 1 Taro Pharmaceuticals, U.S.A., Inc. Vol #: 1
WDL 1 HFD-7 to Taro Pharmaceuticals, U.S.A., Inc. Vol #: 1
2005Q-0211 Health Claim Notification: Whole Grains and Coronary Heart Disease
C 1 Roman Meal Company Vol #: 1

Page created on July 27, 2005 RSC

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management